Harsh Shah, D.O.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Seattle Genetics
    Date added:
    10/01/2021
    Date updated:
    09/23/2024
    Relationship end date:
    10/19/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    BeiGene
    Date added:
    10/01/2021
    Date updated:
    09/23/2024
    Relationship end date:
    10/19/2023
Return to 2022 Cellular Therapy Conference – Translating recent evidence on cellular therapy to real world management of malignancies